December 13, 2021 07:23 AM ESTUpdated 07:36 AM
Coronavirus

Covid-19 roundup: French reg­u­la­tors not ready to give mol­nupi­ravir the OK; Brii claims Chi­na’s first an­ti­body is ef­fec­tive against Omi­cron

Josh Sullivan

Mer­ck’s po­ten­tial Covid-19 treat­ment mol­nupi­ravir will not be used in France, French reg­u­la­tors said Fri­day.

The French Na­tion­al Au­thor­i­ty of Health …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J takes 340B fight with fed­er­al gov­ern­ment to court

Dan­ish biotech Gubra touts ear­ly weight loss da­ta in hot amylin field

Af­ter stock slides, Am­gen ad­dress­es bone den­si­ty talk on obe­si­ty drug

New can­cer class heats up as BioN­Tech buys out Chi­na part­ner and its PD-L1/VEGF drug

Ex­clu­sive: Flag­ship names two CEO-part­ners to lead Va­lo Health, Apri­ori Bio

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times